Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- HC Wainwright & Co. analyst Andrew Fein initiated coverage on ImmunityBio, Inc. (NASDAQ:IBRX) with a Buy rating and announced a price target of $8. ImmunityBio …
Full story available on Benzinga.com
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- HC Wainwright & Co. analyst Andrew Fein initiated coverage on ImmunityBio, Inc. (NASDAQ:IBRX) with a Buy rating and announced a price target of $8. ImmunityBio …
Full story available on Benzinga.com
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
HC Wainwright & Co. analyst Andrew Fein initiated coverage on ImmunityBio, Inc. (NASDAQ:IBRX) with a Buy rating and announced a price target of $8. ImmunityBio …Full story available on Benzinga.com Read MoreADUR, IBRX, News, Top Initiations, TRML, Initiation, Markets, Analyst Ratings, Trading Ideas, IBRX, TRML, ADUR, News, Initiation, Markets, Analyst Ratings, Trading Ideas, Benzinga Markets
